Clinical Trial Update: Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

View source ↗

Summary

This is a completed observational and epidemiologic study led by Novartis to understand the disease course and unmet needs in children with symptomatic moderate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Moderate to Severe Allergic Asthma | Status: COMPLETED